AstraZeneca PLC (AZN)

Industry Drug Manufacturers - General
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

11,872.00p

Buy

11,876.00p

arrow-down-112.00p (-0.94%)

Prices updated at 18 Sep 2024, 17:56 BST
| Prices minimum 15 mins delay
|
Prices in GBX
AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.
FTSE All-Share
arrow-down-0.65%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Most recent dividend payment

0.776
Cash Dividend
08 Aug 2024
25 Jul 2024
09 Aug 2024
09 Sep 2024

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20242.3360-
20232.34600.02
20222.21700.01
20212.02200.00
20202.1600-0.01
20192.18700.03
20182.02000.00
20172.19100.02
20161.9970-0.04
20151.8250-0.01

Total dividend yield data table

Year
chevron-l-regular
chevron-r-regular
Dividend yield (%)Buyback yield (%)
20241.76-
20232.21-
20221.98-
20212.33-
20202.95-
20192.87-
20183.44-
20174.28-
20164.50-
20153.95-

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
20242.3360
20232.3460
20222.2170
20212.0220
20202.1600
20192.1870
20182.0200
20172.1910
20161.9970
20151.8250

% of earnings paid to shareholders data table

YearPayout ratio (%)
202470.08
202376.09
2022221.36
2021252.65
2020147.69
2019175.84
2018143.85
201798.86
2016139.85
2015210.15
Latest Financial Report as of 17 Sep 2024
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.